Cryo Cell International (CCEL) Equity Income (2010 - 2015)

Cryo Cell International has disclosed Equity Income across 6 years of filings, most recently posting -$1164.0 for Q4 2015.

• In Q4 2015, Equity Income rose 99.03% year-over-year to -$1164.0; the TTM figure through Aug 2016 stood at -$1164.0 (up 99.16% YoY), while the FY2015 annual figure was -$18824.0, up 94.81% from the prior year.
• Equity Income held at -$1164.0 in Q4 2015, from -$1164.0 in the prior quarter.
• Over the last five years, Equity Income for CCEL reached as high as -$1164.0 in Q3 2015 and fell as low as -$134802.0 in Q4 2011.
• The 5-year median for Equity Income is -$38450.0 (2012), against an average of -$45867.0.
• Annual changes were most pronounced in 2014 — Equity Income sank 212.54% — and 2015, when it surged 99.03%.
• A 5-year view of Equity Income shows it stood at -$134802.0 in 2011, then soared by 71.48% to -$38450.0 in 2012, then retreated by 0.33% to -$38576.0 in 2013, then slumped by 212.54% to -$120566.0 in 2014, then surged by 99.03% to -$1164.0 in 2015.
• According to Business Quant data, Equity Income over the past three periods registered -$1164.0, -$1164.0, and -$8248.0 for Q4 2015, Q3 2015, and Q2 2015 respectively.